Dr. Jennifer Tsai

Dr. Jennifer Tsai

Dr. Jennifer Tsai

  • Physician in Pediatric Hematology / Oncology Division, Children’s Hospital, Stanford University, CA, USA

Jennifer Tsai, MD is a physician in the pediatric hematology/oncology division at Lucile Packard Children’s Hospital at Stanford University in California, USA. She is conducting preclinical research in the laboratories of Kenneth Weinberg, MD, an expert in stem cell biology, and Daria Mochly-Rosen, PhD, a leading translational biologist, to activate aldehyde metabolism as a potential treatment for Fanconi Anemia. FA is a rare inherited genetic disorder with serious hematologic consequences and cancer predisposition. Jennifer is also developing a biomarker assay for aldehydes in collaboration with the laboratory of chemist Eric Kool, PhD, to support the development of clinical trials for Fanconi Anemia and other conditions related to aldehyde-mediated damage. Jennifer has been passionate about developing novel therapies for hematologic diseases since her first experiences with patients when she worked as a clinical research assistant, which inspired her to become a physician. Her future goal is to become a leader in early phase clinical investigation to improve outcomes for patients. While her current research focuses on a rare disease, her hope is that discoveries made for rare diseases will lead to broader applications to improve human health.